HRT Financial LP Sells 2,102 Shares of Clearmind Medicine Common Stock

HRT Financial LP, a 10% owner of Clearmind Medicine Inc. (CMND), filed a Form 4 disclosing the sale of 2,102 shares of common stock on June 12, 2026. The shares were sold at $3.36 per share, generating approximately $7,062.72 in proceeds. Following this transaction, HRT Financial LP's ownership position decreased to 106,675 shares. The filing was signed by Adam Nunes on June 16, 2026, and covers the reporting period ending June 10, 2026. The transaction was reported as timely and involved direct ownership of the securities. This filing represents routine insider trading activity by a significant shareholder in the pharmaceutical company.